Ascendis Pharma A/S Payments To Acquire Or Redeem Entitys Shares
Ascendis Pharma A/S (ASND) reported Payments To Acquire Or Redeem Entitys Shares of EUR 17.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:PaymentsToAcquireOrRedeemEntitysShares · last filed 2026-02-11
- Ascendis Pharma A/S payments to acquire or redeem entitys shares for the quarter ending 2025-12-31 was 0.00 EUR.
- Ascendis Pharma A/S payments to acquire or redeem entitys shares for the quarter ending 2025-09-30 was 0.00 EUR.
- Ascendis Pharma A/S payments to acquire or redeem entitys shares for the quarter ending 2025-06-30 was 0.00 EUR.
- Ascendis Pharma A/S payments to acquire or redeem entitys shares for the quarter ending 2025-03-31 was 17.40M EUR.
| Period end | Payments To Acquire Or Redeem Entitys Shares 3 month | Payments To Acquire Or Redeem Entitys Shares 6 month | Payments To Acquire Or Redeem Entitys Shares 9 month | Payments To Acquire Or Redeem Entitys Shares 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 0.00 EUR derived: sum of 2 quarters · filed 2026-02-11 | 0.00 EUR derived: sum of 3 quarters · filed 2026-02-11 | 17.40M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 0.00 EUR derived: sum of 2 quarters · filed 2025-11-12 | 17.40M EUR 6-K · filed 2025-11-12 | 17.40M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 0.00 EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 17.40M EUR 6-K · filed 2025-08-07 | 17.40M EUR derived: sum of 3 quarters · filed 2026-02-11 | 17.40M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 17.40M EUR 6-K · filed 2025-05-01 | 17.40M EUR derived: sum of 2 quarters · filed 2026-02-11 | 17.40M EUR derived: sum of 3 quarters · filed 2026-02-11 | |
| 2024-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 0.00 EUR derived: sum of 2 quarters · filed 2026-02-11 | 0.00 EUR 20-F · filed 2026-02-11 | |
| 2024-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 0.00 EUR 6-K · filed 2025-11-12 | ||
| 2024-06-30 | 0.00 EUR 6-K · filed 2025-08-07 | |||
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-02-11 | |||
| 2023-06-30 | 0.00 EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | 0.00 EUR 6-K · filed 2023-09-05 | 2.00K EUR derived: sum of 3 quarters · filed 2025-02-12 | 1.00K EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 0.00 EUR 6-K · filed 2023-04-27 | 2.00K EUR derived: sum of 2 quarters · filed 2025-02-12 | 1.00K EUR derived: sum of 3 quarters · filed 2025-02-12 | 151.00K EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 2.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 1.00K EUR derived: sum of 2 quarters · filed 2025-02-12 | 151.00K EUR derived: sum of 3 quarters · filed 2025-02-12 | 105.31M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | -1.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 149.00K EUR derived: sum of 2 quarters · filed 2023-11-07 | 105.30M EUR 6-K · filed 2023-11-07 | 126.91M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 150.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | 105.30M EUR 6-K · filed 2023-09-05 | 126.91M EUR derived: sum of 3 quarters · filed 2024-02-07 | 126.91M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 105.15M EUR 6-K · filed 2023-04-27 | 126.76M EUR derived: sum of 2 quarters · filed 2024-02-07 | 126.76M EUR derived: sum of 3 quarters · filed 2024-02-07 | 126.76M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 21.61M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 21.61M EUR derived: sum of 2 quarters · filed 2024-02-07 | 21.61M EUR derived: sum of 3 quarters · filed 2024-02-07 | 21.61M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | 0.00 EUR derived: sum of 2 quarters · filed 2022-11-02 | 0.00 EUR 6-K · filed 2022-11-02 | |
| 2021-06-30 | 0.00 EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | 0.00 EUR 6-K · filed 2022-08-10 | ||
| 2021-03-31 | 0.00 EUR 6-K · filed 2022-05-11 |